-
Electronic (PDF)
-
Hard Copy
-
1 - 5 Users
-
1 - 10 Users
-
1 - 15 Users
Psoriasis Drugs - Global Strategic Business Report
Global Industry Analysts, Inc, April 2010, Pages: 568
This report analyzes the worldwide markets for Psoriasis Drugs in US$ Million by the following Drug Administration Routes - Systemic Drugs, and Topical Drugs. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2006 through 2015. The report profiles 69 companies including many key and niche players such as Abbott Laboratories, Amgen Inc., Almirall SA, Astellas Pharma US, Inc., Biogen Idec, Inc., Eisai Co. Ltd., Galderma Laboratories, Isis Pharmaceuticals, Inc., Johnson & Johnson Company, LEO Pharma A/S, Merck & Co., Inc., Novartis AG, Stiefel Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Vertex Pharmaceuticals, Inc., and Wyeth. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
PSORIASIS DRUGS
A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. Executive Summary
1. MARKET OVERVIEW
2. KEY MARKET TRENDS
3. PIPELINE ANALYSIS
4. ALL ABOUT PSORIASIS
5. OVERVIEW OF PSORIASIS TREATMENT
6. SELECT CLINICAL TRIALS
7. PRODUCT LAUNCHES/ APPROVALS
8. RECENT INDUSTRY ACTIVITY
9. FOCUS ON SELECT PLAYERS
10. GLOBAL MARKET PERSPECTIVE
III. MARKET
1. UNITED STATES
2. JAPAN
3. EUROPE
4. REST OF WORLD
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 69 (including Divisions/Subsidiaries - 75)
Region/Country Players
The United States
Canada
Japan
Europe
Germany
The United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific (Excluding Japan)
Middle-East
-Abbott Laboratories (US)
-Amgen Inc. (US)
-Almirall SA (Spain)
-Astellas Pharma US, Inc. (US)
-Biogen Idec, Inc. (US)
-Eisai Co. Ltd. (Japan)
-Galderma Laboratories (Switzerland)
-Isis Pharmaceuticals, Inc. (US)
-Johnson & Johnson Company (US)
-LEO Pharma A/S (Denmark)
-Merck & Co., Inc. (US)
-Novartis AG (Switzerland)
-Stiefel Laboratories, Inc. (US)
-Teva Pharmaceutical Industries Ltd. (Israel)
-Valeant Pharmaceuticals International (US)
-Vertex Pharmaceuticals, Inc. (US)
-Wyeth (US)
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
